SPOTLIGHT: Ranbaxy acquires GSK generic business in Spain

In yet another sign of consolidation in the generics business, India's Ranbaxy Laboratories announced that it has acquired the Mundogen generic business of GlaxoSmithKline in Spain. The acquisition is part of Ranbaxy's strategy to bolster its presence in the European markets. Report